2023 European Thyroid Association clinical practice guidelines for thyroid nodule management
C Durante, L Hegedüs, A Czarniecka… - European Thyroid …, 2023 - etj.bioscientifica.com
With the widespread use of sensitive imaging techniques, which include neck visualization,
a conspicuous number of thyroid nodules emerge and demand attention. Most lesions are …
a conspicuous number of thyroid nodules emerge and demand attention. Most lesions are …
[HTML][HTML] Differentiated thyroid carcinoma: an update
P van Houten, RT Netea-Maier, JW Smit - Best Practice & Research …, 2023 - Elsevier
Differentiated thyroid carcinoma (DTC) is the most common endocrine cancer. Particularly
the incidence of small clinically indolent tumors has been increasing significantly during the …
the incidence of small clinically indolent tumors has been increasing significantly during the …
Advanced imaging and theranostics in thyroid cancer
ME Roseland, YK Dewaraja… - Current Opinion in …, 2022 - journals.lww.com
Advanced imaging and theranostics in thyroid cancer : Current Opinion in Endocrinology,
Diabetes and Obesity Advanced imaging and theranostics in thyroid cancer : Current Opinion …
Diabetes and Obesity Advanced imaging and theranostics in thyroid cancer : Current Opinion …
Quantitative classification and radiomics of [18F]FDG-PET/CT in indeterminate thyroid nodules
EJ de Koster, WA Noortman, JM Mostert, J Booij… - European journal of …, 2022 - Springer
Purpose To evaluate whether quantitative [18F] FDG-PET/CT assessment, including
radiomic analysis of [18F] FDG-positive thyroid nodules, improved the preoperative …
radiomic analysis of [18F] FDG-positive thyroid nodules, improved the preoperative …
A clinically applicable molecular classification of oncocytic cell thyroid nodules
EJ de Koster, WE Corver… - Endocrine-related …, 2023 - erc.bioscientifica.com
Whole chromosome instability with near-whole genome haploidization (GH) and
subsequent endoreduplication is considered a main genomic driver in the tumorigenesis of …
subsequent endoreduplication is considered a main genomic driver in the tumorigenesis of …
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
EJ de Koster, D Vriens, MO van Aken… - European journal of …, 2022 - Springer
Purpose To evaluate cost-effectiveness of an [18F] FDG-PET/CT-driven diagnostic workup
as compared to diagnostic surgery, for thyroid nodules with Bethesda III/IV cytology.[18F] …
as compared to diagnostic surgery, for thyroid nodules with Bethesda III/IV cytology.[18F] …
Molecular Diagnostics and [18F]FDG-PET/CT in Indeterminate Thyroid Nodules: Complementing Techniques or Waste of Valuable Resources?
EJ de Koster, H Morreau, GS Bleumink… - Thyroid, 2024 - liebertpub.com
Background: An accurate preoperative workup of cytologically indeterminate thyroid nodules
(ITN) may rule out malignancy and avoid diagnostic surgery for benign nodules. This study …
(ITN) may rule out malignancy and avoid diagnostic surgery for benign nodules. This study …
European experience with the Afirma Gene Expression Classifier for indeterminate thyroid nodules: A clinical utility study in the Netherlands
I Lončar, EFS van Velsen, ET Massolt… - Head & …, 2023 - Wiley Online Library
Abstract Background The Gene Expression Classifier (GEC) and Genomic Sequencing
Classifier (GSC) were developed to improve risk stratification of indeterminate nodules. Our …
Classifier (GSC) were developed to improve risk stratification of indeterminate nodules. Our …
Integrated Diagnostics of Thyroid Nodules
L Giovanella, A Campennì, M Tuncel… - Cancers, 2024 - mdpi.com
Simple Summary Thyroid nodules are commonly detected in daily clinical practice, and their
diagnosis and therapy usually involve different specialists and various diagnostic and …
diagnosis and therapy usually involve different specialists and various diagnostic and …
Multi-omics and management of follicular carcinoma of the thyroid
TE Luvhengo, I Bombil, A Mokhtari, MS Moeng… - Biomedicines, 2023 - mdpi.com
Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …